APO Research
Talk to an analyst

APO RESEARCH · REPORT

Site-directed Mutagenesis Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Site-directed Mutagenesis Service Market Analysis and Forecast 2026-2032

12 August 2026196 pages

Choose your research edition.

Industry ResearchSite-directed Mutagenesis Service Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Site-directed Mutagenesis Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Site-directed Mutagenesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Site-directed Mutagenesis Service Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Site-directed Mutagenesis Service Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Site-directed Mutagenesis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Site-directed Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Site-directed Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Site-directed Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Site-directed Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Site-directed Mutagenesis Service include Azenta Life Sciences, Thermo Fisher Scientific, Bon Opus Biosciences, Charles Rive, Creative Biogene, Synbio Technologies, Creative Biolabs, NovoPro and Bionexus, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Site-directed Mutagenesis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Site-directed Mutagenesis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Site-directed Mutagenesis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Site-directed Mutagenesis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Site-directed Mutagenesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Site-directed Mutagenesis Service revenue, projected growth trends, production technology, application and end-user industry.

Site-directed Mutagenesis Service Segment by Company

Azenta Life Sciences

Thermo Fisher Scientific

Bon Opus Biosciences

Charles Rive

Creative Biogene

Synbio Technologies

Creative Biolabs

NovoPro

Bionexus

Biotech Desk

NorClone

Eton Bioscience

Syd Labs

Genosphere Biotechnologies

WZ Biosciences

FulenGen

GENEWIZ

iGene Biotechnology

Tsingke

AtaGenix

Zoonbio Biotechnology

GenScript

Eurofins

Applied Biological Materials

Site-directed Mutagenesis Service Segment by Type

Standard Site-directed Mutagenesis Service

Customized Site-directed Mutagenesis Service

Site-directed Mutagenesis Service Segment by Application

Scientific Research

Gene Therapy

Cell Therapy

Others

Site-directed Mutagenesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Site-directed Mutagenesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Site-directed Mutagenesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Site-directed Mutagenesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Site-directed Mutagenesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Site-directed Mutagenesis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Site-directed Mutagenesis Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Site-directed Mutagenesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Standard Site-directed Mutagenesis Service Major Player Table 3. Customized Site-directed Mutagenesis Service Major Player Table 4. Global Site-directed Mutagenesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Scientific Research Major Player Table 6. Gene Therapy Major Player Table 7. Cell Therapy Major Player Table 8. Others Major Player Table 9. Site-directed Mutagenesis Service Industry Trends Table 10. Site-directed Mutagenesis Service Industry Drivers Table 11. Site-directed Mutagenesis Service Industry Opportunities and Challenges Table 12. Site-directed Mutagenesis Service Industry Restraints Table 13. Global Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Site-directed Mutagenesis Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Site-directed Mutagenesis Service Market Share by Region (2021-2026) Table 16. Global Site-directed Mutagenesis Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Site-directed Mutagenesis Service Market Share by Region (2027-2032) Table 18. Global Site-directed Mutagenesis Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Site-directed Mutagenesis Service Revenue Market Share by Players (2021-2026) Table 20. Global Site-directed Mutagenesis Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Site-directed Mutagenesis Service Key Players Headquarters & Area Served Table 22. Global Site-directed Mutagenesis Service Players, Product Type & Application Table 23. Global Site-directed Mutagenesis Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Site-directed Mutagenesis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Site-directed Mutagenesis Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Site-directed Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Site-directed Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Site-directed Mutagenesis Service Revenue Market Share by Type (2021-2026) Table 30. Global Site-directed Mutagenesis Service Revenue Market Share by Type (2027-2032) Table 31. Global Site-directed Mutagenesis Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Site-directed Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Site-directed Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Site-directed Mutagenesis Service Revenue Market Share by Application (2021-2026) Table 35. Global Site-directed Mutagenesis Service Revenue Market Share by Application (2027-2032) Table 36. Azenta Life Sciences Company Information Table 37. Azenta Life Sciences Business Overview Table 38. Azenta Life Sciences Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Azenta Life Sciences Site-directed Mutagenesis Service Product Portfolio Table 40. Azenta Life Sciences Recent Development Table 41. Thermo Fisher Scientific Company Information Table 42. Thermo Fisher Scientific Business Overview Table 43. Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Thermo Fisher Scientific Site-directed Mutagenesis Service Product Portfolio Table 45. Thermo Fisher Scientific Recent Development Table 46. Bon Opus Biosciences Company Information Table 47. Bon Opus Biosciences Business Overview Table 48. Bon Opus Biosciences Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bon Opus Biosciences Site-directed Mutagenesis Service Product Portfolio Table 50. Bon Opus Biosciences Recent Development Table 51. Charles Rive Company Information Table 52. Charles Rive Business Overview Table 53. Charles Rive Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Charles Rive Site-directed Mutagenesis Service Product Portfolio Table 55. Charles Rive Recent Development Table 56. Creative Biogene Company Information Table 57. Creative Biogene Business Overview Table 58. Creative Biogene Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Creative Biogene Site-directed Mutagenesis Service Product Portfolio Table 60. Creative Biogene Recent Development Table 61. Synbio Technologies Company Information Table 62. Synbio Technologies Business Overview Table 63. Synbio Technologies Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Synbio Technologies Site-directed Mutagenesis Service Product Portfolio Table 65. Synbio Technologies Recent Development Table 66. Creative Biolabs Company Information Table 67. Creative Biolabs Business Overview Table 68. Creative Biolabs Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Creative Biolabs Site-directed Mutagenesis Service Product Portfolio Table 70. Creative Biolabs Recent Development Table 71. NovoPro Company Information Table 72. NovoPro Business Overview Table 73. NovoPro Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. NovoPro Site-directed Mutagenesis Service Product Portfolio Table 75. NovoPro Recent Development Table 76. Bionexus Company Information Table 77. Bionexus Business Overview Table 78. Bionexus Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bionexus Site-directed Mutagenesis Service Product Portfolio Table 80. Bionexus Recent Development Table 81. Biotech Desk Company Information Table 82. Biotech Desk Business Overview Table 83. Biotech Desk Site-directed Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Biotech Desk Site-directed Mutagenesis Service Product Portfolio Table 85. Biotech Desk Recent Development Table 86. NorClone Company Information Table 87. NorClone Business Overview Table 88. NorClone Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. NorClone Site-directed Mutagenesis Service Product Portfolio Table 90. NorClone Recent Development Table 91. Eton Bioscience Company Information Table 92. Eton Bioscience Business Overview Table 93. Eton Bioscience Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Eton Bioscience Site-directed Mutagenesis Service Product Portfolio Table 95. Eton Bioscience Recent Development Table 96. Syd Labs Company Information Table 97. Syd Labs Business Overview Table 98. Syd Labs Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Syd Labs Site-directed Mutagenesis Service Product Portfolio Table 100. Syd Labs Recent Development Table 101. Genosphere Biotechnologies Company Information Table 102. Genosphere Biotechnologies Business Overview Table 103. Genosphere Biotechnologies Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Genosphere Biotechnologies Site-directed Mutagenesis Service Product Portfolio Table 105. Genosphere Biotechnologies Recent Development Table 106. WZ Biosciences Company Information Table 107. WZ Biosciences Business Overview Table 108. WZ Biosciences Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. WZ Biosciences Site-directed Mutagenesis Service Product Portfolio Table 110. WZ Biosciences Recent Development Table 111. FulenGen Company Information Table 112. FulenGen Business Overview Table 113. FulenGen Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. FulenGen Site-directed Mutagenesis Service Product Portfolio Table 115. FulenGen Recent Development Table 116. GENEWIZ Company Information Table 117. GENEWIZ Business Overview Table 118. GENEWIZ Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. GENEWIZ Site-directed Mutagenesis Service Product Portfolio Table 120. GENEWIZ Recent Development Table 121. iGene Biotechnology Company Information Table 122. iGene Biotechnology Business Overview Table 123. iGene Biotechnology Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. iGene Biotechnology Site-directed Mutagenesis Service Product Portfolio Table 125. iGene Biotechnology Recent Development Table 126. Tsingke Company Information Table 127. Tsingke Business Overview Table 128. Tsingke Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Tsingke Site-directed Mutagenesis Service Product Portfolio Table 130. Tsingke Recent Development Table 131. AtaGenix Company Information Table 132. AtaGenix Business Overview Table 133. AtaGenix Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. AtaGenix Site-directed Mutagenesis Service Product Portfolio Table 135. AtaGenix Recent Development Table 136. Zoonbio Biotechnology Company Information Table 137. Zoonbio Biotechnology Business Overview Table 138. Zoonbio Biotechnology Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Zoonbio Biotechnology Site-directed Mutagenesis Service Product Portfolio Table 140. Zoonbio Biotechnology Recent Development Table 141. GenScript Company Information Table 142. GenScript Business Overview Table 143. GenScript Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. GenScript Site-directed Mutagenesis Service Product Portfolio Table 145. GenScript Recent Development Table 146. Eurofins Company Information Table 147. Eurofins Business Overview Table 148. Eurofins Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Eurofins Site-directed Mutagenesis Service Product Portfolio Table 150. Eurofins Recent Development Table 151. Applied Biological Materials Company Information Table 152. Applied Biological Materials Business Overview Table 153. Applied Biological Materials Site-directed Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Applied Biological Materials Site-directed Mutagenesis Service Product Portfolio Table 155. Applied Biological Materials Recent Development Table 156. North America Site-directed Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 157. North America Site-directed Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 158. North America Site-directed Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 159. North America Site-directed Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 160. North America Site-directed Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Site-directed Mutagenesis Service Revenue by Country (2021-2026) & (US$ Million) Table 162. North America Site-directed Mutagenesis Service Revenue by Country (US$ Million) & (2027-2032) Table 163. Europe Site-directed Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 164. Europe Site-directed Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 165. Europe Site-directed Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 166. Europe Site-directed Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 167. Europe Site-directed Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Site-directed Mutagenesis Service Revenue by Country (2021-2026) & (US$ Million) Table 169. Europe Site-directed Mutagenesis Service Revenue by Country (US$ Million) & (2027-2032) Table 170. China Site-directed Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 171. China Site-directed Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 172. China Site-directed Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 173. China Site-directed Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Site-directed Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 175. Asia Site-directed Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 176. Asia Site-directed Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 177. Asia Site-directed Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Site-directed Mutagenesis Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Site-directed Mutagenesis Service Revenue by Region (US$ Million) & (2021-2026) Table 180. Asia Site-directed Mutagenesis Service Revenue by Region (US$ Million) & (2027-2032) Table 181. SAMEA Site-directed Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 182. SAMEA Site-directed Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 183. SAMEA Site-directed Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Site-directed Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Site-directed Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Site-directed Mutagenesis Service Revenue by Country (2021-2026) & (US$ Million) Table 187. SAMEA Site-directed Mutagenesis Service Revenue by Country (US$ Million) & (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Site-directed Mutagenesis Service Image Figure 2. Global Site-directed Mutagenesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Site-directed Mutagenesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Standard Site-directed Mutagenesis Service Image Figure 5. Customized Site-directed Mutagenesis Service Image Figure 6. Global Site-directed Mutagenesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Site-directed Mutagenesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Scientific Research Image Figure 9. Gene Therapy Image Figure 10. Cell Therapy Image Figure 11. Others Image Figure 12. Global Site-directed Mutagenesis Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Site-directed Mutagenesis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Site-directed Mutagenesis Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Site-directed Mutagenesis Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Site-directed Mutagenesis Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Site-directed Mutagenesis Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Site-directed Mutagenesis Service Revenue Market Share by Type (2021-2032) Figure 20. Global Site-directed Mutagenesis Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Site-directed Mutagenesis Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Site-directed Mutagenesis Service Revenue Market Share by Application (2021-2032) Figure 23. North America Site-directed Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Site-directed Mutagenesis Service Revenue Share by Type (2021-2032) Figure 25. North America Site-directed Mutagenesis Service Revenue Share by Application (2021-2032) Figure 26. North America Site-directed Mutagenesis Service Revenue Share by Country (2021-2032) Figure 27. United States Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Site-directed Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Site-directed Mutagenesis Service Revenue Share by Type (2021-2032) Figure 32. Europe Site-directed Mutagenesis Service Revenue Share by Application (2021-2032) Figure 33. Europe Site-directed Mutagenesis Service Revenue Share by Country (2021-2032) Figure 34. Germany Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Site-directed Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Site-directed Mutagenesis Service Revenue Share by Type (2021-2032) Figure 44. China Site-directed Mutagenesis Service Revenue Share by Application (2021-2032) Figure 45. Asia Site-directed Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Site-directed Mutagenesis Service Revenue Share by Type (2021-2032) Figure 47. Asia Site-directed Mutagenesis Service Revenue Share by Application (2021-2032) Figure 48. Asia Site-directed Mutagenesis Service Revenue Share by Region (2021-2032) Figure 49. Japan Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Site-directed Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Site-directed Mutagenesis Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Site-directed Mutagenesis Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Site-directed Mutagenesis Service Revenue Share by Country (2021-2032) Figure 59. Brazil Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Site-directed Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Standard Site-directed Mutagenesis Service
  • Customized Site-directed Mutagenesis Service
Applications
  • Scientific Research
  • Gene Therapy
  • Cell Therapy
  • Others
Companies covered
  • Azenta Life Sciences
  • Thermo Fisher Scientific
  • Bon Opus Biosciences
  • Charles Rive
  • Creative Biogene
  • Synbio Technologies
  • Creative Biolabs
  • NovoPro
  • Bionexus
  • Biotech Desk
  • NorClone
  • Eton Bioscience
  • Syd Labs
  • Genosphere Biotechnologies
  • WZ Biosciences
  • FulenGen
  • GENEWIZ
  • iGene Biotechnology
  • Tsingke
  • AtaGenix
  • Zoonbio Biotechnology
  • GenScript
  • Eurofins
  • Applied Biological Materials

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Site-directed Mutagenesis Service Market by Type
  3. 1.2.1 Global Site-directed Mutagenesis Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Standard Site-directed Mutagenesis Service
  5. 1.2.3 Customized Site-directed Mutagenesis Service
  6. 1.3 Site-directed Mutagenesis Service Market by Application
  7. 1.3.1 Global Site-directed Mutagenesis Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Scientific Research
  9. 1.3.3 Gene Therapy
  10. 1.3.4 Cell Therapy
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Site-directed Mutagenesis Service Market Dynamics
  1. 2.1 Site-directed Mutagenesis Service Industry Trends
  2. 2.2 Site-directed Mutagenesis Service Industry Drivers
  3. 2.3 Site-directed Mutagenesis Service Industry Opportunities and Challenges
  4. 2.4 Site-directed Mutagenesis Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Site-directed Mutagenesis Service Market Perspective (2021-2032)
  2. 3.2 Global Site-directed Mutagenesis Service Growth Trends by Region
  3. 3.2.1 Global Site-directed Mutagenesis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Site-directed Mutagenesis Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Site-directed Mutagenesis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Site-directed Mutagenesis Service Revenue by Players
  2. 4.1.1 Global Site-directed Mutagenesis Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Site-directed Mutagenesis Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Site-directed Mutagenesis Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Site-directed Mutagenesis Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Site-directed Mutagenesis Service Key Players Headquarters & Area Served
  7. 4.4 Global Site-directed Mutagenesis Service Players, Product Type & Application
  8. 4.5 Global Site-directed Mutagenesis Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Site-directed Mutagenesis Service Market CR5 and HHI
  11. 4.6.3 2025 Site-directed Mutagenesis Service Tier 1, Tier 2, and Tier 3
5 Site-directed Mutagenesis Service Market Size by Type
  1. 5.1 Global Site-directed Mutagenesis Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Site-directed Mutagenesis Service Revenue by Type (2021-2032)
  3. 5.3 Global Site-directed Mutagenesis Service Revenue Market Share by Type (2021-2032)
6 Site-directed Mutagenesis Service Market Size by Application
  1. 6.1 Global Site-directed Mutagenesis Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Site-directed Mutagenesis Service Revenue by Application (2021-2032)
  3. 6.3 Global Site-directed Mutagenesis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Azenta Life Sciences
  2. 7.1.1 Azenta Life Sciences Company Information
  3. 7.1.2 Azenta Life Sciences Business Overview
  4. 7.1.3 Azenta Life Sciences Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Azenta Life Sciences Site-directed Mutagenesis Service Product Portfolio
  6. 7.1.5 Azenta Life Sciences Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 Bon Opus Biosciences
  14. 7.3.1 Bon Opus Biosciences Company Information
  15. 7.3.2 Bon Opus Biosciences Business Overview
  16. 7.3.3 Bon Opus Biosciences Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bon Opus Biosciences Site-directed Mutagenesis Service Product Portfolio
  18. 7.3.5 Bon Opus Biosciences Recent Developments
  19. 7.4 Charles Rive
  20. 7.4.1 Charles Rive Company Information
  21. 7.4.2 Charles Rive Business Overview
  22. 7.4.3 Charles Rive Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles Rive Site-directed Mutagenesis Service Product Portfolio
  24. 7.4.5 Charles Rive Recent Developments
  25. 7.5 Creative Biogene
  26. 7.5.1 Creative Biogene Company Information
  27. 7.5.2 Creative Biogene Business Overview
  28. 7.5.3 Creative Biogene Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biogene Site-directed Mutagenesis Service Product Portfolio
  30. 7.5.5 Creative Biogene Recent Developments
  31. 7.6 Synbio Technologies
  32. 7.6.1 Synbio Technologies Company Information
  33. 7.6.2 Synbio Technologies Business Overview
  34. 7.6.3 Synbio Technologies Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Synbio Technologies Site-directed Mutagenesis Service Product Portfolio
  36. 7.6.5 Synbio Technologies Recent Developments
  37. 7.7 Creative Biolabs
  38. 7.7.1 Creative Biolabs Company Information
  39. 7.7.2 Creative Biolabs Business Overview
  40. 7.7.3 Creative Biolabs Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Biolabs Site-directed Mutagenesis Service Product Portfolio
  42. 7.7.5 Creative Biolabs Recent Developments
  43. 7.8 NovoPro
  44. 7.8.1 NovoPro Company Information
  45. 7.8.2 NovoPro Business Overview
  46. 7.8.3 NovoPro Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NovoPro Site-directed Mutagenesis Service Product Portfolio
  48. 7.8.5 NovoPro Recent Developments
  49. 7.9 Bionexus
  50. 7.9.1 Bionexus Company Information
  51. 7.9.2 Bionexus Business Overview
  52. 7.9.3 Bionexus Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bionexus Site-directed Mutagenesis Service Product Portfolio
  54. 7.9.5 Bionexus Recent Developments
  55. 7.10 Biotech Desk
  56. 7.10.1 Biotech Desk Company Information
  57. 7.10.2 Biotech Desk Business Overview
  58. 7.10.3 Biotech Desk Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Biotech Desk Site-directed Mutagenesis Service Product Portfolio
  60. 7.10.5 Biotech Desk Recent Developments
  61. 7.11 NorClone
  62. 7.11.1 NorClone Company Information
  63. 7.11.2 NorClone Business Overview
  64. 7.11.3 NorClone Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 NorClone Site-directed Mutagenesis Service Product Portfolio
  66. 7.11.5 NorClone Recent Developments
  67. 7.12 Eton Bioscience
  68. 7.12.1 Eton Bioscience Company Information
  69. 7.12.2 Eton Bioscience Business Overview
  70. 7.12.3 Eton Bioscience Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Eton Bioscience Site-directed Mutagenesis Service Product Portfolio
  72. 7.12.5 Eton Bioscience Recent Developments
  73. 7.13 Syd Labs
  74. 7.13.1 Syd Labs Company Information
  75. 7.13.2 Syd Labs Business Overview
  76. 7.13.3 Syd Labs Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Syd Labs Site-directed Mutagenesis Service Product Portfolio
  78. 7.13.5 Syd Labs Recent Developments
  79. 7.14 Genosphere Biotechnologies
  80. 7.14.1 Genosphere Biotechnologies Company Information
  81. 7.14.2 Genosphere Biotechnologies Business Overview
  82. 7.14.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Product Portfolio
  84. 7.14.5 Genosphere Biotechnologies Recent Developments
  85. 7.15 WZ Biosciences
  86. 7.15.1 WZ Biosciences Company Information
  87. 7.15.2 WZ Biosciences Business Overview
  88. 7.15.3 WZ Biosciences Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 WZ Biosciences Site-directed Mutagenesis Service Product Portfolio
  90. 7.15.5 WZ Biosciences Recent Developments
  91. 7.16 FulenGen
  92. 7.16.1 FulenGen Company Information
  93. 7.16.2 FulenGen Business Overview
  94. 7.16.3 FulenGen Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 FulenGen Site-directed Mutagenesis Service Product Portfolio
  96. 7.16.5 FulenGen Recent Developments
  97. 7.17 GENEWIZ
  98. 7.17.1 GENEWIZ Company Information
  99. 7.17.2 GENEWIZ Business Overview
  100. 7.17.3 GENEWIZ Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 GENEWIZ Site-directed Mutagenesis Service Product Portfolio
  102. 7.17.5 GENEWIZ Recent Developments
  103. 7.18 iGene Biotechnology
  104. 7.18.1 iGene Biotechnology Company Information
  105. 7.18.2 iGene Biotechnology Business Overview
  106. 7.18.3 iGene Biotechnology Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 iGene Biotechnology Site-directed Mutagenesis Service Product Portfolio
  108. 7.18.5 iGene Biotechnology Recent Developments
  109. 7.19 Tsingke
  110. 7.19.1 Tsingke Company Information
  111. 7.19.2 Tsingke Business Overview
  112. 7.19.3 Tsingke Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Tsingke Site-directed Mutagenesis Service Product Portfolio
  114. 7.19.5 Tsingke Recent Developments
  115. 7.20 AtaGenix
  116. 7.20.1 AtaGenix Company Information
  117. 7.20.2 AtaGenix Business Overview
  118. 7.20.3 AtaGenix Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 AtaGenix Site-directed Mutagenesis Service Product Portfolio
  120. 7.20.5 AtaGenix Recent Developments
  121. 7.21 Zoonbio Biotechnology
  122. 7.21.1 Zoonbio Biotechnology Company Information
  123. 7.21.2 Zoonbio Biotechnology Business Overview
  124. 7.21.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Product Portfolio
  126. 7.21.5 Zoonbio Biotechnology Recent Developments
  127. 7.22 GenScript
  128. 7.22.1 GenScript Company Information
  129. 7.22.2 GenScript Business Overview
  130. 7.22.3 GenScript Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 GenScript Site-directed Mutagenesis Service Product Portfolio
  132. 7.22.5 GenScript Recent Developments
  133. 7.23 Eurofins
  134. 7.23.1 Eurofins Company Information
  135. 7.23.2 Eurofins Business Overview
  136. 7.23.3 Eurofins Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Eurofins Site-directed Mutagenesis Service Product Portfolio
  138. 7.23.5 Eurofins Recent Developments
  139. 7.24 Applied Biological Materials
  140. 7.24.1 Applied Biological Materials Company Information
  141. 7.24.2 Applied Biological Materials Business Overview
  142. 7.24.3 Applied Biological Materials Site-directed Mutagenesis Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Applied Biological Materials Site-directed Mutagenesis Service Product Portfolio
  144. 7.24.5 Applied Biological Materials Recent Developments
8 North America
  1. 8.1 North America Site-directed Mutagenesis Service Revenue (2021-2032)
  2. 8.2 North America Site-directed Mutagenesis Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Site-directed Mutagenesis Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Site-directed Mutagenesis Service Revenue by Type (2027-2032)
  5. 8.3 North America Site-directed Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Site-directed Mutagenesis Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Site-directed Mutagenesis Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Site-directed Mutagenesis Service Revenue by Application (2027-2032)
  9. 8.5 North America Site-directed Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Site-directed Mutagenesis Service Revenue by Country
  11. 8.6.1 North America Site-directed Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Site-directed Mutagenesis Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Site-directed Mutagenesis Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Site-directed Mutagenesis Service Revenue (2021-2032)
  2. 9.2 Europe Site-directed Mutagenesis Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Site-directed Mutagenesis Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Site-directed Mutagenesis Service Revenue by Type (2027-2032)
  5. 9.3 Europe Site-directed Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Site-directed Mutagenesis Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Site-directed Mutagenesis Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Site-directed Mutagenesis Service Revenue by Application (2027-2032)
  9. 9.5 Europe Site-directed Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Site-directed Mutagenesis Service Revenue by Country
  11. 9.6.1 Europe Site-directed Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Site-directed Mutagenesis Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Site-directed Mutagenesis Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Site-directed Mutagenesis Service Revenue (2021-2032)
  2. 10.2 China Site-directed Mutagenesis Service Revenue by Type (2021-2032)
  3. 10.2.1 China Site-directed Mutagenesis Service Revenue by Type (2021-2026)
  4. 10.2.2 China Site-directed Mutagenesis Service Revenue by Type (2027-2032)
  5. 10.3 China Site-directed Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 10.4 China Site-directed Mutagenesis Service Revenue by Application (2021-2032)
  7. 10.4.1 China Site-directed Mutagenesis Service Revenue by Application (2021-2026)
  8. 10.4.2 China Site-directed Mutagenesis Service Revenue by Application (2027-2032)
  9. 10.5 China Site-directed Mutagenesis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Site-directed Mutagenesis Service Revenue (2021-2032)
  2. 11.2 Asia Site-directed Mutagenesis Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Site-directed Mutagenesis Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Site-directed Mutagenesis Service Revenue by Type (2027-2032)
  5. 11.3 Asia Site-directed Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Site-directed Mutagenesis Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Site-directed Mutagenesis Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Site-directed Mutagenesis Service Revenue by Application (2027-2032)
  9. 11.5 Asia Site-directed Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Site-directed Mutagenesis Service Revenue by Country
  11. 11.6.1 Asia Site-directed Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Site-directed Mutagenesis Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Site-directed Mutagenesis Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Site-directed Mutagenesis Service Revenue (2021-2032)
  2. 12.2 SAMEA Site-directed Mutagenesis Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Site-directed Mutagenesis Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Site-directed Mutagenesis Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Site-directed Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Site-directed Mutagenesis Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Site-directed Mutagenesis Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Site-directed Mutagenesis Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Site-directed Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Site-directed Mutagenesis Service Revenue by Country
  11. 12.6.1 SAMEA Site-directed Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Site-directed Mutagenesis Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Site-directed Mutagenesis Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst